speb/financial-data huggingface dataset:
AAME cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 1516000.00
AAME cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -101000.00
AAME income_statement (quarterly, 2025-03-31) — +Total Revenue: 50125000.00
AAME balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 43042000.00
AAME balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 57425000.00
AAME cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 149000.00
AAME income_statement (quarterly, 2025-03-31) — Basic Average Shares: 20400000.00
AAME income_statement (quarterly, 2025-03-31) — Basic EPS: 0.03
AAME cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 35570000.00
AAME cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -264000.00
AAME balance_sheet (quarterly, 2025-03-31) — Capital Stock: 22456000.00
AAME balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 35903000.00
AAME balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 67272000.00
AAME cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4000.00
AAME cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 1059000.00
AAME cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -722000.00
AAME cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3683000.00
AAME cash_flow (quarterly, 2025-03-31) — Change In Receivables: 7370000.00
AAME cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -899000.00
AAME cash_flow (quarterly, 2025-03-31) — Changes In Cash: 333000.00
AAME balance_sheet (quarterly, 2025-03-31) — Common Stock: 22401000.00
AAME balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 102330000.00
AAME balance_sheet (quarterly, 2025-03-31) — Current Debt: 4022000.00
AAME balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4022000.00
AAME cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 232000.00
AAME cash_flow (quarterly, 2025-03-31) — Deferred Tax: 232000.00
AAME cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 77000.00
AAME income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 20400000.00
AAME income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.03
AAME income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 703000.00
AAME income_statement (quarterly, 2025-03-31) — EBIT: 1809000.00
AAME cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 155000.00
AAME cash_flow (quarterly, 2025-03-31) — End Cash Position: 35903000.00
AAME cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4000.00
AAME cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -986000.00
AAME balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -16234000.00
AAME balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2544000.00
AAME cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 315000.00
AAME income_statement (quarterly, 2025-03-31) — Interest Expense: 774000.00
AAME income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 774000.00
AAME cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 788000.00
AAME balance_sheet (quarterly, 2025-03-31) — Invested Capital: 140090000.00
AAME cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 1059000.00
AAME balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 224352000.00
AAME balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 1238000.00
AAME cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
AAME balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 4022000.00
AAME balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 33738000.00
AAME balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 33738000.00
AAME cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
AAME balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1238000.00
AAME income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 31913000.00
AAME balance_sheet (quarterly, 2025-03-31) — Net Debt: 1857000.00
AAME income_statement (quarterly, 2025-03-31) — Net Income: 802000.00
AAME income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 703000.00
AAME income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 802000.00
AAME income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 802000.00
AAME income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 802000.00
AAME cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 802000.00
AAME income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 802000.00
AAME income_statement (quarterly, 2025-03-31) — Net Interest Income: -774000.00
AAME cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 1323000.00
AAME cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
AAME income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -774000.00
AAME cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -264000.00
AAME income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 31913000.00
AAME balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 99841000.00
AAME income_statement (quarterly, 2025-03-31) — Normalized Income: 802000.00
AAME cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -722000.00
AAME cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 155000.00
AAME income_statement (quarterly, 2025-03-31) — Operating Revenue: 50125000.00
AAME balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 20397228.00
AAME balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -16234000.00
AAME income_statement (quarterly, 2025-03-31) — Other Income Expense: 3000.00
AAME cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -473000.00
AAME income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 4723000.00
AAME balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 31369000.00
AAME balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 27771000.00
AAME balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 55000.00
AAME balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 55000.00
AAME income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 99000.00
AAME balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 55000.00
AAME income_statement (quarterly, 2025-03-31) — Pretax Income: 1035000.00
AAME cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -4000.00
AAME cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -5846000.00
AAME cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -264000.00
AAME balance_sheet (quarterly, 2025-03-31) — Receivables: 43042000.00
AAME income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 77000.00
AAME balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 46150000.00
AAME cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 7169000.00
AAME balance_sheet (quarterly, 2025-03-31) — Share Issued: 22400894.00
AAME cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2000.00
AAME balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 102385000.00
AAME balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 99786000.00
AAME income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AAME income_statement (quarterly, 2025-03-31) — Tax Provision: 233000.00
AAME income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
AAME balance_sheet (quarterly, 2025-03-31) — Total Assets: 388436000.00
AAME balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 136123000.00
AAME balance_sheet (quarterly, 2025-03-31) — Total Debt: 37760000.00
AAME balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 102385000.00
AAME income_statement (quarterly, 2025-03-31) — Total Expenses: 49090000.00
AAME balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 286051000.00
AAME balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 2003666.00
AAME balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 7412000.00
AAME cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -767000.00
AAME income_statement (quarterly, 2025-06-30) — +Total Revenue: 55290000.00
AAME balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 72611000.00
AAME balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 57425000.00
AAME cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -592000.00
AAME income_statement (quarterly, 2025-06-30) — Basic Average Shares: 20725000.00
AAME income_statement (quarterly, 2025-06-30) — Basic EPS: 0.16
AAME cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 35903000.00
AAME cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -170000.00
AAME balance_sheet (quarterly, 2025-06-30) — Capital Stock: 22456000.00
AAME balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 46423000.00
AAME balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 84293000.00
AAME cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -407000.00
AAME cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 1649000.00
AAME cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 9278000.00
AAME cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 2435000.00
AAME cash_flow (quarterly, 2025-06-30) — Change In Receivables: -29566000.00
AAME cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 7862000.00
AAME cash_flow (quarterly, 2025-06-30) — Changes In Cash: 10520000.00
AAME balance_sheet (quarterly, 2025-06-30) — Common Stock: 22401000.00
AAME balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 106113000.00
AAME balance_sheet (quarterly, 2025-06-30) — Current Debt: 4021000.00
AAME balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 4021000.00
AAME cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 628000.00
AAME cash_flow (quarterly, 2025-06-30) — Deferred Tax: 628000.00
AAME cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 103000.00
AAME income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 22106667.00
AAME income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.15
AAME income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 3216000.00
AAME income_statement (quarterly, 2025-06-30) — EBIT: 4989000.00
AAME cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 137000.00
AAME cash_flow (quarterly, 2025-06-30) — End Cash Position: 46423000.00
AAME cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -407000.00
AAME cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 9108000.00
AAME balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -15667000.00
AAME balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2544000.00
AAME cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 412000.00
AAME income_statement (quarterly, 2025-06-30) — Interest Expense: 773000.00
AAME income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 773000.00
AAME cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 771000.00
AAME balance_sheet (quarterly, 2025-06-30) — Invested Capital: 143872000.00
AAME cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 1649000.00
AAME balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 225841000.00
AAME balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 1238000.00
AAME cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
AAME balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 4021000.00
AAME balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 33738000.00
AAME balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 33738000.00
AAME cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
AAME balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1238000.00
AAME income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: 33647000.00
AAME income_statement (quarterly, 2025-06-30) — Net Income: 3316000.00
AAME income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 3216000.00
AAME income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 3316000.00
AAME income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 3316000.00
AAME income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 3316000.00
AAME cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 3316000.00
AAME income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 3316000.00
AAME income_statement (quarterly, 2025-06-30) — Net Interest Income: -773000.00
AAME cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 1819000.00
AAME cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
AAME income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -773000.00
AAME cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -170000.00
AAME income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 33647000.00
AAME balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 103624000.00
AAME income_statement (quarterly, 2025-06-30) — Normalized Income: 3316000.00
AAME cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 9278000.00
AAME cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 121000.00
AAME income_statement (quarterly, 2025-06-30) — Operating Revenue: 55290000.00
AAME balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 20397228.00
AAME balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -15667000.00
AAME income_statement (quarterly, 2025-06-30) — Other Income Expense: 3000.00
AAME cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 449000.00
AAME income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 3784000.00
AAME balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 37870000.00
AAME balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 29899000.00
AAME balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 55000.00
AAME balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 55000.00
AAME income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 100000.00
AAME balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 55000.00
AAME income_statement (quarterly, 2025-06-30) — Pretax Income: 4216000.00
AAME cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
AAME cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -7185000.00
AAME cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -170000.00
AAME balance_sheet (quarterly, 2025-06-30) — Receivables: 72611000.00
AAME income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 103000.00
AAME balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 49366000.00
AAME cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 9004000.00
AAME balance_sheet (quarterly, 2025-06-30) — Share Issued: 22400894.00
AAME cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 0.00
AAME balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 106168000.00
AAME balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 103569000.00
AAME income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AAME income_statement (quarterly, 2025-06-30) — Tax Provision: 900000.00
AAME income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
AAME balance_sheet (quarterly, 2025-06-30) — Total Assets: 429339000.00
AAME balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 139906000.00
AAME balance_sheet (quarterly, 2025-06-30) — Total Debt: 37759000.00
AAME balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 106168000.00
AAME income_statement (quarterly, 2025-06-30) — Total Expenses: 51074000.00
AAME balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 323171000.00
AAME balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 2003666.00
AAME balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 7412000.00
AAME cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -2609000.00
AAME income_statement (quarterly, 2025-09-30) — +Total Revenue: 53760000.00
AAME balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 65093000.00
AAME balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 57425000.00
AAME cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -474000.00
AAME income_statement (quarterly, 2025-09-30) — Basic Average Shares: 20397000.00
AAME income_statement (quarterly, 2025-09-30) — Basic EPS: 0.02
AAME cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 46423000.00
AAME cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -31000.00
AAME balance_sheet (quarterly, 2025-09-30) — Capital Stock: 22456000.00
AAME balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 34444000.00
AAME balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 79216000.00
AAME cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
AAME cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
AAME cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -18621000.00
AAME cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 6642000.00
AAME cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4031000.00
AAME cash_flow (quarterly, 2025-09-30) — Change In Receivables: 7503000.00
AAME cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 5599000.00
AAME cash_flow (quarterly, 2025-09-30) — Changes In Cash: -11979000.00
AAME balance_sheet (quarterly, 2025-09-30) — Common Stock: 22401000.00
AAME cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: 0.00
AAME balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 109433000.00
AAME balance_sheet (quarterly, 2025-09-30) — Current Debt: 4021000.00
AAME balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4021000.00
AAME cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -396000.00
AAME cash_flow (quarterly, 2025-09-30) — Deferred Tax: -396000.00
AAME cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 97000.00
AAME income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 20397000.00
AAME income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.02
AAME income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 477000.00
AAME income_statement (quarterly, 2025-09-30) — EBIT: 1548000.00
AAME cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 99000.00
AAME cash_flow (quarterly, 2025-09-30) — End Cash Position: 34444000.00
AAME cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
AAME cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 6611000.00
AAME cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -2000.00
AAME balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -12824000.00
AAME balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2544000.00
AAME cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 225000.00
AAME income_statement (quarterly, 2025-09-30) — Interest Expense: 779000.00
AAME income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 779000.00
AAME cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 783000.00
AAME balance_sheet (quarterly, 2025-09-30) — Invested Capital: 147192000.00
AAME cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -18621000.00
AAME balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 247139000.00
AAME balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 1238000.00
AAME cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
AAME balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 4021000.00
AAME balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 33738000.00
AAME balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 33738000.00
AAME cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
AAME balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 1238000.00
AAME income_statement (quarterly, 2025-09-30) — Loss Adjustment Expense: 35471000.00
AAME balance_sheet (quarterly, 2025-09-30) — Net Debt: 3315000.00
AAME income_statement (quarterly, 2025-09-30) — Net Income: 577000.00
AAME income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 477000.00
AAME income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 577000.00
AAME income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 577000.00
AAME income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 577000.00
AAME cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 577000.00
AAME income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 577000.00
AAME income_statement (quarterly, 2025-09-30) — Net Interest Income: -779000.00
AAME cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -18590000.00
AAME cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
AAME income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -779000.00
AAME cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -31000.00
AAME income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 35471000.00
AAME balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 106944000.00
AAME income_statement (quarterly, 2025-09-30) — Normalized Income: 577000.00
AAME cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 6642000.00
AAME cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 97000.00
AAME income_statement (quarterly, 2025-09-30) — Operating Revenue: 53760000.00
AAME balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 20397228.00
AAME balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -12824000.00
AAME income_statement (quarterly, 2025-09-30) — Other Income Expense: 1000.00
AAME cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 294000.00
AAME income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 3786000.00
AAME balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 44772000.00
AAME balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 34030000.00
AAME balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 55000.00
AAME balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 55000.00
AAME income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 100000.00
AAME balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 55000.00
AAME income_statement (quarterly, 2025-09-30) — Pretax Income: 769000.00
AAME cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
AAME cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -29270000.00
AAME cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -31000.00
AAME balance_sheet (quarterly, 2025-09-30) — Receivables: 65093000.00
AAME income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 97000.00
AAME balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 49843000.00
AAME cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 10680000.00
AAME balance_sheet (quarterly, 2025-09-30) — Share Issued: 22400894.00
AAME cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 0.00
AAME balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 109488000.00
AAME balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 106889000.00
AAME income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AAME income_statement (quarterly, 2025-09-30) — Tax Provision: 192000.00
AAME income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
AAME balance_sheet (quarterly, 2025-09-30) — Total Assets: 430855000.00
AAME balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 143226000.00
AAME balance_sheet (quarterly, 2025-09-30) — Total Debt: 37759000.00
AAME balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 109488000.00
AAME income_statement (quarterly, 2025-09-30) — Total Expenses: 52991000.00
AAME balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 321367000.00
AAME balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 2003666.00
AAME balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 7412000.00
AAME cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 848000.00
AAMI income_statement (annual, 2021-12-31) — Amortization: 100000.00
AAMI cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 100000.00
AAMI cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 100000.00
AAMI income_statement (annual, 2021-12-31) — Amortization Of Intangibles Income Statement: 100000.00
AAMI cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
AAMI balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
AAMI cash_flow (annual, 2021-12-31) — Cash From Discontinued Financing Activities: -27200000.00
AAMI cash_flow (annual, 2021-12-31) — Cash From Discontinued Investing Activities: 952400000.00
AAMI cash_flow (annual, 2021-12-31) — Cash From Discontinued Operating Activities: -7100000.00
AAMI cash_flow (annual, 2021-12-31) — Dividend Received Cfo: 57100000.00
AAMI income_statement (annual, 2021-12-31) — Earnings From Equity Interest: 2600000.00
AAMI cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: -2600000.00
AAMI cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -48600000.00
AAMI income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 48600000.00
AAMI income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
AAMI balance_sheet (annual, 2021-12-31) — Long Term Debt: 394900000.00
AAMI cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 61600000.00
AAMI income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 768300000.00
AAMI cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
AAMI cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 31200000.00
AAMI income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 100000.00
AAMI cash_flow (annual, 2021-12-31) — Sale Of Business: 61600000.00
AAMI cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 176000000.00
AAMI cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -176000000.00
AAMI income_statement (annual, 2022-12-31) — +Operating Expense: 89700000.00
AAMI income_statement (annual, 2022-12-31) — +Total Revenue: 417200000.00
AAMI balance_sheet (annual, 2022-12-31) — Accounts Payable: 5000000.00
AAMI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 122500000.00
AAMI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -106500000.00
AAMI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1500000.00
AAMI income_statement (annual, 2022-12-31) — Amortization: 100000.00
AAMI cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 100000.00
AAMI cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 100000.00
AAMI income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 100000.00
AAMI cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
AAMI income_statement (annual, 2022-12-31) — Basic Average Shares: 42056278.00
AAMI income_statement (annual, 2022-12-31) — Basic EPS: 2.39
AAMI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 252100000.00
AAMI cash_flow (annual, 2022-12-31) — Capital Expenditure: -16100000.00
AAMI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 75800000.00
AAMI balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
AAMI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 108400000.00
AAMI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 108400000.00
AAMI cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1200000.00
AAMI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -233700000.00
AAMI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -13000000.00
AAMI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 116800000.00
AAMI cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: 0.00
AAMI cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: 0.00
AAMI cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 0.00
AAMI cash_flow (annual, 2022-12-31) — Change In Account Payable: 2700000.00
AAMI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -33400000.00
AAMI cash_flow (annual, 2022-12-31) — Change In Payable: 2700000.00
AAMI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -30700000.00
AAMI cash_flow (annual, 2022-12-31) — Change In Receivables: 40100000.00
AAMI cash_flow (annual, 2022-12-31) — Change In Working Capital: 9400000.00
AAMI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 42200000.00
AAMI cash_flow (annual, 2022-12-31) — Changes In Cash: -129900000.00
AAMI balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
AAMI cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -1200000.00
AAMI balance_sheet (annual, 2022-12-31) — Common Stock Equity: -21600000.00
AAMI cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
AAMI cash_flow (annual, 2022-12-31) — Common Stock Payments: -103200000.00
AAMI income_statement (annual, 2022-12-31) — Cost Of Revenue: 159600000.00
AAMI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 26300000.00
AAMI balance_sheet (annual, 2022-12-31) — Current Assets: 245700000.00
AAMI balance_sheet (annual, 2022-12-31) — Current Liabilities: 35900000.00
AAMI cash_flow (annual, 2022-12-31) — Deferred Income Tax: 6400000.00
AAMI cash_flow (annual, 2022-12-31) — Deferred Tax: 6400000.00
AAMI cash_flow (annual, 2022-12-31) — Depreciation: 18500000.00
AAMI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 18600000.00
AAMI income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 18600000.00
AAMI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 18600000.00
AAMI income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 18600000.00
AAMI income_statement (annual, 2022-12-31) — Depreciation Income Statement: 18500000.00
AAMI balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 2200000.00
AAMI income_statement (annual, 2022-12-31) — Diluted Average Shares: 43156269.00
AAMI income_statement (annual, 2022-12-31) — Diluted EPS: 2.33
AAMI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 100600000.00
AAMI cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 0.00
AAMI income_statement (annual, 2022-12-31) — EBIT: 165300000.00
AAMI income_statement (annual, 2022-12-31) — EBITDA: 183900000.00
AAMI income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 0.00
AAMI cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 0.00
AAMI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1000000.00
AAMI balance_sheet (annual, 2022-12-31) — Employee Benefits: 151800000.00
AAMI cash_flow (annual, 2022-12-31) — End Cash Position: 121200000.00
AAMI cash_flow (annual, 2022-12-31) — Financing Cash Flow: -233700000.00
AAMI cash_flow (annual, 2022-12-31) — Free Cash Flow: 100700000.00
AAMI cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 3400000.00
AAMI cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
AAMI income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
AAMI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -200000.00
AAMI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -10600000.00
AAMI income_statement (annual, 2022-12-31) — General And Administrative Expense: 71100000.00
AAMI balance_sheet (annual, 2022-12-31) — Goodwill: 20300000.00
AAMI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 20300000.00
AAMI balance_sheet (annual, 2022-12-31) — Gross PPE: 214100000.00
AAMI income_statement (annual, 2022-12-31) — Gross Profit: 257600000.00
AAMI income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
AAMI cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 36800000.00
AAMI balance_sheet (annual, 2022-12-31) — Income Tax Payable: 4600000.00
AAMI income_statement (annual, 2022-12-31) — Interest Expense: 20500000.00
AAMI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 20500000.00
AAMI income_statement (annual, 2022-12-31) — Interest Income: 800000.00
AAMI income_statement (annual, 2022-12-31) — Interest Income Non Operating: 800000.00
AAMI cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 16000000.00
AAMI balance_sheet (annual, 2022-12-31) — Interest Payable: 5700000.00
AAMI balance_sheet (annual, 2022-12-31) — Invested Capital: 251900000.00
AAMI cash_flow (annual, 2022-12-31) — Investing Cash Flow: -13000000.00
AAMI balance_sheet (annual, 2022-12-31) — Investments And Advances: 50300000.00
AAMI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
AAMI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 214000000.00
AAMI balance_sheet (annual, 2022-12-31) — Leases: 29000000.00
AAMI balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
AAMI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 75800000.00
AAMI balance_sheet (annual, 2022-12-31) — Long Term Debt: 273500000.00
AAMI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 349300000.00
AAMI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 214000000.00
AAMI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -340100000.00
AAMI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 125200000.00
AAMI balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
AAMI income_statement (annual, 2022-12-31) — Minority Interests: 0.00
AAMI cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
AAMI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -103200000.00
AAMI balance_sheet (annual, 2022-12-31) — Net Debt: 165100000.00
AAMI income_statement (annual, 2022-12-31) — Net Income: 100600000.00
AAMI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 100600000.00
AAMI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 100600000.00
AAMI income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
AAMI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 100600000.00
AAMI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 100600000.00
AAMI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 100600000.00
AAMI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 100600000.00
AAMI income_statement (annual, 2022-12-31) — Net Interest Income: -19700000.00
AAMI cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 3100000.00
AAMI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -126100000.00
AAMI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -126100000.00
AAMI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -19700000.00
AAMI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -3200000.00
AAMI balance_sheet (annual, 2022-12-31) — Net PPE: 107600000.00
AAMI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -16100000.00
AAMI cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -125000000.00
AAMI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -41900000.00
AAMI balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 64700000.00
AAMI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 64700000.00
AAMI income_statement (annual, 2022-12-31) — Normalized EBITDA: 187300000.00
AAMI income_statement (annual, 2022-12-31) — Normalized Income: 102963000.00
AAMI cash_flow (annual, 2022-12-31) — Operating Cash Flow: 116800000.00
AAMI cash_flow (annual, 2022-12-31) — Operating Gains Losses: 6600000.00
AAMI income_statement (annual, 2022-12-31) — Operating Income: 167900000.00
AAMI income_statement (annual, 2022-12-31) — Operating Revenue: 417200000.00
AAMI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 41435087.00
AAMI cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
AAMI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -10600000.00
AAMI income_statement (annual, 2022-12-31) — Other Gand A: 71100000.00
AAMI income_statement (annual, 2022-12-31) — Other Income Expense: -3400000.00
AAMI cash_flow (annual, 2022-12-31) — Other Non Cash Items: -24800000.00
AAMI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 30100000.00
AAMI balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1100000.00
AAMI balance_sheet (annual, 2022-12-31) — Other Properties: 59900000.00
AAMI income_statement (annual, 2022-12-31) — Other Special Charges: 3200000.00
AAMI income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
AAMI balance_sheet (annual, 2022-12-31) — Payables: 9600000.00
AAMI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 35900000.00
AAMI income_statement (annual, 2022-12-31) — Pretax Income: 144800000.00
AAMI balance_sheet (annual, 2022-12-31) — Properties: 0.00
AAMI cash_flow (annual, 2022-12-31) — Purchase Of Investment: -5500000.00
AAMI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -16100000.00
AAMI balance_sheet (annual, 2022-12-31) — Receivables: 124500000.00
AAMI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 159600000.00
AAMI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 18600000.00
AAMI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -340100000.00
AAMI cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -103200000.00
AAMI balance_sheet (annual, 2022-12-31) — Restricted Cash: 12800000.00
AAMI balance_sheet (annual, 2022-12-31) — Retained Earnings: -12500000.00
AAMI cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
AAMI cash_flow (annual, 2022-12-31) — Sale Of Investment: 8600000.00
AAMI income_statement (annual, 2022-12-31) — Selling General And Administration: 71100000.00
AAMI balance_sheet (annual, 2022-12-31) — Share Issued: 41435087.00
AAMI cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 214000000.00
AAMI cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -339000000.00
AAMI income_statement (annual, 2022-12-31) — Special Income Charges: -3200000.00
AAMI balance_sheet (annual, 2022-12-31) — Stockholders Equity: -21600000.00
AAMI balance_sheet (annual, 2022-12-31) — Tangible Book Value: -41900000.00
AAMI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -1037000.00
AAMI income_statement (annual, 2022-12-31) — Tax Provision: 44200000.00
AAMI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.31
AAMI balance_sheet (annual, 2022-12-31) — Taxes Receivable: 2000000.00
AAMI balance_sheet (annual, 2022-12-31) — Total Assets: 518700000.00
AAMI balance_sheet (annual, 2022-12-31) — Total Capitalization: 251900000.00
AAMI balance_sheet (annual, 2022-12-31) — Total Debt: 349300000.00
AAMI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -21600000.00
AAMI income_statement (annual, 2022-12-31) — Total Expenses: 249300000.00
AAMI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 540300000.00
AAMI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 273000000.00
AAMI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 504400000.00
AAMI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 167900000.00
AAMI balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4600000.00
AAMI income_statement (annual, 2022-12-31) — Total Unusual Items: -3400000.00
AAMI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -3400000.00
AAMI balance_sheet (annual, 2022-12-31) — Working Capital: 209800000.00
AAMI income_statement (annual, 2023-12-31) — +Operating Expense: 99900000.00
AAMI income_statement (annual, 2023-12-31) — +Total Revenue: 426600000.00
AAMI balance_sheet (annual, 2023-12-31) — Accounts Payable: 8800000.00
AAMI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 143400000.00
AAMI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -119500000.00
AAMI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 0.00
AAMI income_statement (annual, 2023-12-31) — Amortization: 0.00
AAMI cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 0.00
AAMI cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 0.00
AAMI income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 0.00
AAMI income_statement (annual, 2023-12-31) — Basic Average Shares: 41500000.00
AAMI income_statement (annual, 2023-12-31) — Basic EPS: 1.59
AAMI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 121200000.00
AAMI cash_flow (annual, 2023-12-31) — Capital Expenditure: -13800000.00
AAMI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 72400000.00
AAMI balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
AAMI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 146800000.00
AAMI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 146800000.00
AAMI cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -2000000.00
AAMI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 1800000.00
AAMI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -43900000.00
AAMI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 68300000.00
AAMI cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: 0.00
AAMI cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: 0.00
AAMI cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: 0.00
AAMI cash_flow (annual, 2023-12-31) — Change In Account Payable: 5200000.00
AAMI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 10200000.00
AAMI cash_flow (annual, 2023-12-31) — Change In Payable: 5200000.00
AAMI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 15400000.00
AAMI cash_flow (annual, 2023-12-31) — Change In Receivables: -24200000.00
AAMI cash_flow (annual, 2023-12-31) — Change In Working Capital: -8800000.00
AAMI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -24400000.00
AAMI cash_flow (annual, 2023-12-31) — Changes In Cash: 26200000.00
AAMI balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
AAMI cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -2000000.00
AAMI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 40200000.00
AAMI cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
AAMI cash_flow (annual, 2023-12-31) — Common Stock Payments: -3300000.00
AAMI income_statement (annual, 2023-12-31) — Cost Of Revenue: 220700000.00
AAMI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 30500000.00
AAMI balance_sheet (annual, 2023-12-31) — Current Assets: 293700000.00
AAMI balance_sheet (annual, 2023-12-31) — Current Liabilities: 41900000.00
AAMI cash_flow (annual, 2023-12-31) — Deferred Income Tax: -6000000.00
AAMI cash_flow (annual, 2023-12-31) — Deferred Tax: -6000000.00
AAMI cash_flow (annual, 2023-12-31) — Depreciation: 17300000.00
AAMI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 17300000.00
AAMI income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 17300000.00
AAMI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 17300000.00
AAMI income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 17300000.00
AAMI income_statement (annual, 2023-12-31) — Depreciation Income Statement: 17300000.00
AAMI balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 100000.00
AAMI income_statement (annual, 2023-12-31) — Diluted Average Shares: 42500000.00
AAMI income_statement (annual, 2023-12-31) — Diluted EPS: 1.55
AAMI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 65800000.00
AAMI cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 0.00
AAMI income_statement (annual, 2023-12-31) — EBIT: 116100000.00
AAMI income_statement (annual, 2023-12-31) — EBITDA: 133400000.00
AAMI income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 0.00
AAMI cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
AAMI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 200000.00
AAMI balance_sheet (annual, 2023-12-31) — Employee Benefits: 168800000.00
AAMI cash_flow (annual, 2023-12-31) — End Cash Position: 147600000.00
AAMI cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1800000.00
AAMI cash_flow (annual, 2023-12-31) — Free Cash Flow: 54500000.00
AAMI cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -6700000.00
AAMI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
AAMI income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
AAMI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 4000000.00
AAMI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -6700000.00
AAMI income_statement (annual, 2023-12-31) — General And Administrative Expense: 82600000.00
AAMI balance_sheet (annual, 2023-12-31) — Goodwill: 20300000.00
AAMI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 20300000.00
AAMI balance_sheet (annual, 2023-12-31) — Gross PPE: 220900000.00
AAMI income_statement (annual, 2023-12-31) — Gross Profit: 205900000.00
AAMI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 37800000.00
AAMI balance_sheet (annual, 2023-12-31) — Income Tax Payable: 2600000.00
AAMI income_statement (annual, 2023-12-31) — Interest Expense: 19600000.00
AAMI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 19600000.00
AAMI income_statement (annual, 2023-12-31) — Interest Income: 6100000.00
AAMI income_statement (annual, 2023-12-31) — Interest Income Non Operating: 6100000.00
AAMI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 15500000.00
AAMI balance_sheet (annual, 2023-12-31) — Interest Payable: 5600000.00
AAMI balance_sheet (annual, 2023-12-31) — Invested Capital: 314100000.00
AAMI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -43900000.00
AAMI balance_sheet (annual, 2023-12-31) — Investments And Advances: 98600000.00
AAMI cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
AAMI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 113500000.00
AAMI balance_sheet (annual, 2023-12-31) — Leases: 30000000.00
AAMI balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
AAMI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 72400000.00
AAMI balance_sheet (annual, 2023-12-31) — Long Term Debt: 273900000.00
AAMI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 346300000.00